Cardiovascular Disease in Primary Sjögren’s Syndrome

Author(s): Onorina Berardicurti*, Piero Ruscitti, Paola Cipriani, Francesco Ciccia, Vasiliki Liakouli, Giuliana Guggino, Francesco Carubbi, Paola Di Benedetto, Giovanni Triolo, Roberto Giacomelli

Journal Name: Reviews on Recent Clinical Trials

Volume 13 , Issue 3 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: A close relationship between rheumatic diseases and cardiovascular disease (CVD) has been reported, accounting for the higher mortality and morbidity observed in these patients. In the last years, it has been clearly reported that patients affected by primary Sjögren’s syndrome (pSS) experienced an increased risk of CVD.

Objective: This review aimed at investigating CVD, traditional cardiovascular (CV) risk factors and possible targeted therapeutic strategies in pSS patients.

Method: Available literature concerning CV risk factors in pSS patients has been selected and discussed.

Conclusion: Disease-related characteristics and traditional CV risk factors contribute to observed atherosclerotic damage in pSS patients. The pro-inflammatory mediators together with hypertension and type 2 diabetes, which are more prevalent in pSS patients, determine the increased CV burden. Future studies are needed to fully elucidate the role of possible targeted therapies.

Keywords: Atherosclerosis, cardiovascular disease, cardiovascular risk, comorbidity, endothelial damage, Sjögren syndrome.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 15 March, 2018
Page: [164 - 169]
Pages: 6
DOI: 10.2174/1574887113666180315130336
Price: $65

Article Metrics

PDF: 43
PRC: 1